Webinar
Going global - UK/US market expansion: What life sciences firms need to know
A strategic overview of entering/scaling operations across the Atlantic
For UK-based Life Sciences and Pharma companies, the US remains a key market for international growth, but navigating expansion across the Atlantic brings significant financial, regulatory, and operational complexity.
In this episode, experts from MHA and the Baker Tilly International (BTI) network unpack the core challenges that UK companies face when entering or scaling in the US market, including cross-border tax structuring, regulatory compliance, supply chain planning and talent strategy.
With practical insight and deep international expertise, this discussion highlights how MHA and the BTI network empower UK firms to expand with clarity, confidence and full compliance — positioning them for long-term success in the world’s largest healthcare market.
Register today to gain the insights you need for a successful US expansion.
Target Regions:
- Primary: UK (key clusters) and Ireland
Target Audiences:
- Life sciences/pharma firms expanding internationally
- Key roles: CEOs, CFOs, COOs, regulatory heads, finance/operations/legal leads and strategy consultants
Speakers:
- Yogan Patel, Head of Life Sciences & MedTech, MHA (An independent member of Baker Tilly international)
- Jonathan Dowding, Tax Director, MHA (An independent member of Baker Tilly international)
- Darren Jones, Principal, Baker Tilly US
